BioMAS Ltd.
BioMAS Ltd. (BioMAS) is a pharmaceutical company engaged in the development of innovative pharmaceuticals. It is focused on the development of therapeutics based on two small tellurium compounds such as AS101 and SAS It aimed for the treatment of various conditions including: viral infections, skin disorders, malignancies and neurological disorders. The company provides new non-toxic AS101/SAS drugs and new therapeutic strategy which binds through Arg-Gly-Asp (RGD) mimetic drugs and this drugs are involved in both pre-clinical studies and clinical trials to treat various areas such as central nervous system, dermatological disorders and papilloma virus. The company has an license agreement with international pharmaceutical and biotech companies which are involved in cancer,CNS, anti-viral and dermatology disorder markets. The company is headquartered in Kfar Saba, Israel.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

